Literature DB >> 8604254

Prevotella intermedia fimbriae mediate hemagglutination.

K P Leung1, H Fukushima, W E Nesbitt, W B Clark.   

Abstract

Our earlier studies demonstrated that clinical strains of Prevotella intermedia, isolated from human periodontal pockets, possess various types of fimbria (surface appendages) as determined ultrastructurally. These bacteria have the ability to agglutinate selected mammalian erythrocytes. Hemagglutinating activity exhibited by these cells may be attributable to these surface structures. Strain 17, which possess fimbriae of 8 nm in diameter and readily agglutinates human, monkey, sheep, rabbit, and mouse erythrocytes was selected to determine whether these fimbriae possessed the hemagglutinating activity. Fimbriae were mechanically sheared, concentrated by ammonium sulfate precipitation, solubilized in 10 mM Tris-HCl buffer containing 0.5% deoxycholate and partly purified by ultracentrifugation in a 10-50% linear sucrose gradient. Isolated fimbriae banded at a density of 1.20-1.15 g/ml, appeared fairly uniform ultrastructurally, and possessed hemagglutinating activity. The hemagglutinating activity of P. intermedia whole cells and isolated fimbriae was reduced by treatment with proteases and eliminated by treatment with heat at 80 degrees C for 10 min. The optimal pH for the hemagglutination was 7.0. In the process of hemagglutination, P. intermedia whole cells and isolated fimbriae bound to rabbit erythrocytes as observed by: (a) decrease in the hemagglutinating activity of bacterial whole cells and isolated fimbriae after incubation with rabbit erythrocytes, (b) increase in hemagglutinating activity of the red cells used for absorption, and (c) the presence of P. intermedia whole cells and fimbriae on red cells after absorption as revealed by immunoelectron microscopy. Both the immune immunoglobulin G of the rabbit polyclonal anti-fimbriae antibody and the immune immunoglobulin G and its Fab fragments of the murine monoclonal anti-fimbriae antibody were effective inhibitors of hemagglutination mediated by isolated fimbriae. Immunogold labeling showed that the monoclonal antibody bound specifically to P. intermedia fimbriae. These results collectively suggest that the hemagglutination exhibited by P. intermedia may be attributable to the fimbriae or the fimbrial-associated components.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8604254     DOI: 10.1111/j.1399-302x.1996.tb00335.x

Source DB:  PubMed          Journal:  Oral Microbiol Immunol        ISSN: 0902-0055


  6 in total

1.  Prevotella intermedia stimulates expansion of Vbeta-specific CD4(+) T cells.

Authors:  K P Leung; B A Torres
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

2.  Insertional Inactivation and Gene Complementation of Prevotella intermedia Type IX Secretion System Reveals Its Indispensable Roles in Black Pigmentation, Hemagglutination, Protease Activity of Interpain A, and Biofilm Formation.

Authors:  Mariko Naito; Mikio Shoji; Keiko Sato; Koji Nakayama
Journal:  J Bacteriol       Date:  2022-07-13       Impact factor: 3.476

3.  Invasion of human oral epithelial cells by Prevotella intermedia.

Authors:  B R Dorn; K L Leung; A Progulske-Fox
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

4.  Characteristics of Prevotella intermedia-specific CD4+ T cell clones from peripheral blood of a chronic adult periodontitis patient.

Authors:  A Wassenaar; C Reinhardus; L Abraham-Inpijn; A Snijders; F Kievits
Journal:  Clin Exp Immunol       Date:  1998-07       Impact factor: 4.330

5.  A chinese case of prevotella intermedia and streptococcus constellatus intracranial mixed infection.

Authors:  Shanying Mo; Liuhua Wei; Hongmou Chen; Rui Li; Shuping Li; Guolan Luo
Journal:  Metab Brain Dis       Date:  2017-11-02       Impact factor: 3.584

6.  Comparative genome analysis of Prevotella intermedia strain isolated from infected root canal reveals features related to pathogenicity and adaptation.

Authors:  Yunfeng Ruan; Lu Shen; Yan Zou; Zhengnan Qi; Jun Yin; Jie Jiang; Liang Guo; Lin He; Zijiang Chen; Zisheng Tang; Shengying Qin
Journal:  BMC Genomics       Date:  2015-02-25       Impact factor: 3.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.